Literature DB >> 29499269

Oncogenic KRas mobility in the membrane and signaling response.

Ruth Nussinov1, Chung-Jung Tsai2, Hyunbum Jang2.   

Abstract

Ras signaling initiates at the plasma membrane. Thus, Ras behavior at the membrane and how it relates to its interactions with Raf and PI3Kα, are of immense interest. Here we review factors influencing Ras lateral diffusion. We then ask whether oncogenic Ras diffusion speed in the membrane is important for signaling response times and whether it affects ubiquitously all pathways. We suggest that if Ras expression is sufficiently high to dimerize (or form nanoclusters), signaling response of those pathways where dimers (or nanoclusters) are involved corresponds to the speed with which Ras molecules travel in the membrane. On average, the faster the rate at which Ras travels to dimerize, the shorter the time to MAPK signaling; but not PI3Kα. However, we argue that KRas speed may not play an important functional role because changes in mobility at this scale are unlikely to be significant. In line with this, despite the anchors' variability, lateral diffusion speeds of KRas and HRas are similar, as is that of Lck kinase; however, even though with similar anchor, Cdc42 mobility presents a different pattern, commensurate with its role in the positioning of the apical domain, suggesting that mobility evolved for function.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cdc42; HRAS; K-Ras; K-Ras4A; K-Ras4B; KRAS4A; KRAS4B; Lck kinase; NRAS

Mesh:

Substances:

Year:  2018        PMID: 29499269     DOI: 10.1016/j.semcancer.2018.02.009

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  12 in total

Review 1.  Inhibition of Nonfunctional Ras.

Authors:  Ruth Nussinov; Hyunbum Jang; Attila Gursoy; Ozlem Keskin; Vadim Gaponenko
Journal:  Cell Chem Biol       Date:  2021-01-12       Impact factor: 8.116

Review 2.  Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs.

Authors:  Ruth Nussinov; Mingzhen Zhang; Ryan Maloney; Yonglan Liu; Chung-Jung Tsai; Hyunbum Jang
Journal:  J Mol Biol       Date:  2022-04-01       Impact factor: 6.151

Review 3.  The Mystery of Rap1 Suppression of Oncogenic Ras.

Authors:  Ruth Nussinov; Hyunbum Jang; Mingzhen Zhang; Chung-Jung Tsai; Anna A Sablina
Journal:  Trends Cancer       Date:  2020-03-02

4.  The Structural Basis of the Farnesylated and Methylated KRas4B Interaction with Calmodulin.

Authors:  Hyunbum Jang; Avik Banerjee; Kendra Marcus; Lee Makowski; Carla Mattos; Vadim Gaponenko; Ruth Nussinov
Journal:  Structure       Date:  2019-09-05       Impact factor: 5.006

5.  Arl2-Mediated Allosteric Release of Farnesylated KRas4B from Shuttling Factor PDEδ.

Authors:  E Sila Ozdemir; Hyunbum Jang; Attila Gursoy; Ozlem Keskin; Ruth Nussinov
Journal:  J Phys Chem B       Date:  2018-07-18       Impact factor: 2.991

Review 6.  Signaling in the crowded cell.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  Curr Opin Struct Biol       Date:  2021-07-02       Impact factor: 6.809

Review 7.  PI3K Driver Mutations: A Biophysical Membrane-Centric Perspective.

Authors:  Mingzhen Zhang; Hyunbum Jang; Ruth Nussinov
Journal:  Cancer Res       Date:  2020-10-12       Impact factor: 13.312

Review 8.  Autoinhibition in Ras effectors Raf, PI3Kα, and RASSF5: a comprehensive review underscoring the challenges in pharmacological intervention.

Authors:  Ruth Nussinov; Mingzhen Zhang; Chung-Jung Tsai; Tsung-Jen Liao; David Fushman; Hyunbum Jang
Journal:  Biophys Rev       Date:  2018-09-29

Review 9.  Does Ras Activate Raf and PI3K Allosterically?

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  Front Oncol       Date:  2019-11-15       Impact factor: 6.244

10.  Recapitulation of cell-like KRAS4b membrane dynamics on complex biomimetic membranes.

Authors:  Rebika Shrestha; Peter Frank; Dwight V Nissley; Thomas J Turbyville
Journal:  iScience       Date:  2021-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.